1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C Virus

The RNA-dependent RNA polymerase (NS5B) of hepatitis C virus (HCV) is an unusually attractive target for drug discovery since it contains five distinct drugable sites. The success of novel antiviral therapies will require nonnucleoside inhibitors to be active in at least patients infected with HCV o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nyanguile, Origène, Devogelaere, Benoit, Vijgen, Leen, Van den Broeck, Walter, Pauwels, Frederik, Cummings, Maxwell D., De Bondt, Hendrik L., Vos, Ann M., Berke, Jan M., Lenz, Oliver, Vandercruyssen, Geneviève, Vermeiren, Katrien, Mostmans, Wendy, Dehertogh, Pascale, Delouvroy, Frédéric, Vendeville, Sandrine, VanDyck, Koen, Dockx, Koen, Cleiren, Erna, Raboisson, Pierre, Simmen, Kenneth A., Fanning, Gregory C.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2010
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2826027/
https://ncbi.nlm.nih.gov/pubmed/20071590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01980-09
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars